A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
Browsing: Clinical Breakthroughs
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
In recent Northwestern Medicine clinical trials, an experimental drug improved survival rates for patients with advanced midgut neuroendocrine tumors compared to a standard therapy.
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
When Major League Baseball players travel in a way that misaligns their internal 24-hour clock with the natural environment and its cycle of sunlight, they suffer negative consequences, according to a recent study.
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
Children with congenital heart disease have a higher risk of epilepsy through adulthood, according to a recent Northwestern Medicine study.
A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.